Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiolPSYCHIATRY RESEARCHIF3.92024-09-010OAAI
Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and N-Acylethanolamines by Liquid Chromatography-Tandem Mass SpectrometryCANNABIS AND CANNABINOID RESEARCHIF2.72023-08-0110OAAI
Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental stateFRONTIERS IN PSYCHIATRYIF3.22023-03-033OAAI
Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy VolunteersFRONTIERS IN PSYCHIATRYIF3.22021-03-2624OAAI
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy VolunteersFRONTIERS IN PSYCHIATRYIF3.22020-11-1326OAAI
Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humansCURRENT OPINION IN PSYCHIATRYIF4.92020-01-0142PREAI
Right care, first time: a highly personalised and measurement-based care model to manage youth mental healthMEDICAL JOURNAL OF AUSTRALIAIF8.52019-11-03102OAAI
Cannabis use and psychosis: a review of reviewsEUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCEIF3.72019-09-28158PREAI
Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stagesELIFEIF02018-09-27107OA
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological InterventionCNS DRUGSIF7.42018-07-1835PREAI
Familial abnormalities of endocannabinoid signaling in schizophrenia精神分裂症患者内源性大麻素信号的家族性异常WORLD JOURNAL OF BIOLOGICAL PSYCHIATRYIF3.82018-03-2230PREAI
Neural correlates of binocular depth inversion illusion in antipsychotic-naive first-episode schizophrenia patientsEUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCEIF3.72018-03-193PREAI
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosisBRITISH JOURNAL OF PSYCHIATRYIF7.62018-01-02147OAAI
Differential Association of Anandamide Levels with Binocular Depth Inversion Illusion Scores in SchizophreniaBIOLOGICAL PSYCHIATRYIF92017-05-011PREAI
Association of anandamide with altered binocular depth inversion illusion in schizophreniaWORLD JOURNAL OF BIOLOGICAL PSYCHIATRYIF3.82016-11-1125PREAI
MODULATION OF THE ENDOCANNABINOID SYSTEM AS A POTENTIAL NEW TARGET IN THE TREATMENT OF SCHIZOPHRENIASCHIZOPHRENIA RESEARCHIF3.52014-04-015PREAI
THE BINOCULAR DEPTH INVERSION ILLUSION TEST - A BASIC MEASURE OF PERCEPTUAL INTEGRATIONSCHIZOPHRENIA RESEARCHIF3.52014-04-010PREAI
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disordersEUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCEIF3.72013-11-2064PREAI
Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naive, first episode schizophreniaSCHIZOPHRENIA RESEARCHIF3.52013-11-0178PREAI
A TWIN STUDY ON ABNORMALITIES OF ENDOCANNABINOID FUNCTIONING IN SCHIZOPHRENIA AND BIPOLAR DISORDERSCHIZOPHRENIA RESEARCHIF3.52012-04-010PREAI